Rogers Campbell
Rogers Campbell, CMO, reported a transaction classified as exercise at Heartflow, Inc. involving 850.000000 shares for an estimated $0.00. Reported holdings after the transaction were 70783.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 18, 2026
- Filing date
- Sep 21, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
HTFL price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0001464521-26-000152 Stock Option
- Transaction date
- Sep 18, 2026 Filed Sep 21, 2026, 10:19 PM · 3d delay
- Shares
- 850 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 70,783 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-20 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Medical Officer
- F1
The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on June 16, 2026.
- F2
Includes the sale of 6,503 shares of common stock held and the option exercise and sale of 13,179 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by th…
- F3
These stock options are fully exercisable.
- F4
The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
0 other transactions
0 recent txs